Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Zachary Melchiode, Tivoli Nguyen, Omar Dawood, Graham A. Bobo & Wayne J.G. Hellstrom. (2023) Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments. Expert Opinion on Investigational Drugs 32:7, pages 635-642.
Read now
Read now
Bassant Elbardisy, Sally Galal, Doaa A. Abdelmonsif & Nabila Boraie. (2019) Intranasal Tadalafil nanoemulsions: formulation, characterization and pharmacodynamic evaluation. Pharmaceutical Development and Technology 24:9, pages 1083-1094.
Read now
Read now
Jonathan L. Zurawin, Carrie A. Stewart, James E. Anaissie, Faysal A. Yafi & Wayne J. G. Hellstrom. (2016) Avanafil for the treatment of erectile dysfunction. Expert Review of Clinical Pharmacology 9:9, pages 1163-1170.
Read now
Read now
Usama A Fahmy. (2015) Nanoethosomal transdermal delivery of vardenafil for treatment of erectile dysfunction: optimization, characterization, and in vivo evaluation. Drug Design, Development and Therapy 9, pages 6129-6137.
Read now
Read now
Eric G Katz, Ronny BW Tan, Daniel Rittenberg & Wayne J Hellstrom. (2014) Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility. Therapeutics and Clinical Risk Management 10, pages 701-711.
Read now
Read now
Min Chul Cho & Jae-Seung Paick. (2014) Udenafil for the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management 10, pages 341-354.
Read now
Read now
Articles from other publishers (68)
Ahmed K. ElHady, Dalia S. El-Gamil, Mohammad Abdel-Halim & Ashraf H. Abadi. (2023) Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives. Pharmaceuticals 16:9, pages 1266.
Crossref
Crossref
Lei Xu, Lilei Sun, Peng Su, Teng Ma, Yingcong Yu, Haibin Liu & Xianfeng Huang. (2023) Identification of Potential Inhibitors of PDE5 based on Structure-based
Virtual Screening Approaches. Current Computer-Aided Drug Design 19:3, pages 234-242.
Crossref
Crossref
Kawthar K. Abla, Amina T. Mneimneh, Ahmed N. Allam & Mohammed M. Mehanna. (2023) Application of Box-Behnken Design in the Preparation, Optimization, and In-Vivo Pharmacokinetic Evaluation of Oral Tadalafil-Loaded Niosomal Film. Pharmaceutics 15:1, pages 173.
Crossref
Crossref
Iman Shamohammadi, Seyedmohammad Kazemeyni, Mohammadali Sadighi, Tara Hasanzadeh & Alireza Dizavi. (2022) Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial. Asian Journal of Urology.
Crossref
Crossref
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, Giovanni Rossini, Virginia Zamponi, Soraya Olana, Antongiulio Faggiano, Paolo Pozzilli, Andrea M. Isidori & Daniele Gianfrilli. (2021) Erectile dysfunction and diabetes: A melting pot of circumstances and treatments. Diabetes/Metabolism Research and Reviews 38:2.
Crossref
Crossref
J. O. Aiyekomogbon, D. U. Itanyi, T. Atim & J. B. Igashi. (2021) Evaluation of erectile dysfunction in the ageing men using colour Doppler sonography. African Journal of Urology 27:1.
Crossref
Crossref
Peter Sandner, Markus Follmann, Eva Becker‐Pelster, Michael G. Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig & Johannes‐Peter Stasch. (2021) Soluble GC stimulators and activators: Past, present and future. British Journal of Pharmacology.
Crossref
Crossref
Abdulrahman Alwhaibi, Sary Alsanea, Ziyad Alrabiah, Fars K. Alanazi, Badraddin M. Al-Hadiya & Hisham S. Abou-Auda. (2021) Pharmacokinetic profile of sildenafil citrate in healthy Middle Eastern Males: Comparison with other ethnicities. Saudi Pharmaceutical Journal 29:12, pages 1498-1505.
Crossref
Crossref
Natalie Längst, Julia Adler, Olga Schweigert, Felicia Kleusberg, Melanie Cruz Santos, Amelie Knauer, Matthias Sausbier, Tanja Zeller, Peter Ruth & Robert Lukowski. (2021) Cyclic GMP-Dependent Regulation of Vascular Tone and Blood Pressure Involves Cysteine-Rich LIM-Only Protein 4 (CRP4). International Journal of Molecular Sciences 22:18, pages 9925.
Crossref
Crossref
Victor H Aguilera-Alvarez, Bilal Khan Mohammed, Aqsa Fatima, Ankit Patel, Avaniben Patel, Frederick N Gyabaah, Jobby John, Abbas Iqbal, Sidra Naz, Affan Munir, Ammer Haffar, Muhammad Irfan & Muhammad Hanif. (2021) The Role and Efficacy of Coenzyme Q10 in the Management of Erectile Dysfunction in a Hypertensive Male: An Interventional Study. Cureus.
Crossref
Crossref
Ahmad Yusri Mohd Yusop, Linda Xiao & Shanlin Fu. (2020) Suspected‐target and non‐targeted screenings of phosphodiesterase 5 inhibitors in herbal remedies using liquid chromatography–quadrupole time‐of‐flight–mass spectrometry. Drug Testing and Analysis 13:5, pages 965-976.
Crossref
Crossref
Christopher I. Sayegh, Joseph M. Caputo, Vinson Wang & Denise Asafu-Adjei. 2021. Design and Implementation of the Modern Men’s Health Center. Design and Implementation of the Modern Men’s Health Center
93
126
.
Bernhard Kutscher. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry
1
69
.
Mohamed A. Shaaban, Yaseen A.M.M. Elshaier, Ali H. Hammad, Nahla A. Farag, Haredy Hassan Haredy, Ahmed A. AbdEl-Ghany & Khaled O. Mohamed. (2020) Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors. Bioorganic & Medicinal Chemistry Letters 30:16, pages 127337.
Crossref
Crossref
Dae Yul Yang. (2020) Pharmacological management of male sexual dysfunction. Journal of the Korean Medical Association 63:6, pages 356-364.
Crossref
Crossref
Xian-Feng Huang, Yan-Hua Dong, Jin-Hui Wang, Heng-Ming Ke, Guo-Qiang Song & De-Feng Xu. (2020) Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters 30:9, pages 127097.
Crossref
Crossref
Jinze Li, Lei Peng, Dehong Cao, Lujia He, Yunxiang Li & Qiang Wei. (2019) Avanafil for the Treatment of men With Erectile Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American Journal of Men's Health 13:5, pages 155798831988076.
Crossref
Crossref
Osama A.A. Ahmed & Shaimaa M. Badr-Eldin. (2019) Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. International Journal of Pharmaceutics 570, pages 118657.
Crossref
Crossref
Gelson Perin, Helen A. Goulart, Liane K. Soares, Thiago J. Peglow, Ricardo F. Schumacher, Mikaela P. Pinz, Angélica S. Reis, Cristiane Luchese & Ethel A. Wilhelm. (2018) Synthesis and Pharmacological Evaluation of Novel Selenoethers Glycerol Derivatives for the Treatment of Pain and Inflammation: Involvement of Nitrergic and Glutamatergic Systems. Applied Biochemistry and Biotechnology 187:4, pages 1398-1423.
Crossref
Crossref
Emmanuele A. Jannini & Stéphane Droupy. (2019) Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil. Sexual Medicine 7:1, pages 1-10.
Crossref
Crossref
Jenny Z. Wang, Stephanie Le, Claire Alexanian, Sucharita Boddu, Alexander Merleev, Alina Marusina & Emanual Maverakis. (2019) No Causal Link between Phosphodiesterase Type 5 Inhibition and Melanoma. The World Journal of Men's Health 37:3, pages 313.
Crossref
Crossref
S. I. Gamidov, T. V. Shatylko, N. G. Gasanov & N. A. Naumov. (2018) The use of tadalafil on demand in specific categories of patients. Andrology and Genital Surgery 19:4, pages 15-20.
Crossref
Crossref
M. Abu El‐Hamd. (2018) Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: A randomised placebo‐controlled clinical trial. Andrologia 50:5.
Crossref
Crossref
Wei Liu, Patrick J. Antonelli, Philipp Dahm, Tobias Gerhard, Joseph A.C. Delaney, Richard Segal, Stephen Crystal & Almut G. Winterstein. (2018) Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study. Pharmacoepidemiology and Drug Safety 27:6, pages 587-595.
Crossref
Crossref
Mary Lee & Roohollah Sharifi. (2018) Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails. Drugs & Aging 35:3, pages 175-187.
Crossref
Crossref
Adriaan Tuiten, Kim van Rooij, Jos Bloemers, Christoph Eisenegger, Jack van Honk, Rob Kessels, Sheryl Kingsberg, Leonard R. Derogatis, Leo de Leede, Jeroen Gerritsen, Hans P.F. Koppeschaar, Berend Olivier, Walter Everaerd, Henderik W. Frijlink, Daniël Höhle, Robert P.J. de Lange, Koen B.E. Böcker & James G. Pfaus. (2018) Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials. The Journal of Sexual Medicine 15:2, pages 201-216.
Crossref
Crossref
Adriaan Tuiten, Frits Michiels, Koen BE Böcker, Daniël Höhle, Jack van Honk, Robert PJ de Lange, Kim van Rooij, Rob Kessels, Jos Bloemers, Jeroen Gerritsen, Paddy Janssen, Leo de Leede, John-Jules Meyer, Walter Everaerd, Henderik W Frijlink, Hans PF Koppeschaar, Berend Olivier & James G Pfaus. (2018) Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial. Women's Health 14, pages 174550651878897.
Crossref
Crossref
Peter Sandner, Daniel P. Zimmer, G. Todd Milne, Markus Follmann, Adrian Hobbs & Johannes-Peter Stasch. 2021. Reactive Oxygen Species. Reactive Oxygen Species
355
394
.
Vanessa D. G. Silva, Angélica S. Reis, Mikaela P. Pinz, Caren A. R. da Fonseca, Luis Fernando B. Duarte, Juliano A. Roehrs, Diego Alves, Cristiane Luchese & Ethel A. Wilhelm. (2017) Further analysis of acute antinociceptive and anti-inflammatory actions of 4-phenylselenyl-7-chloroquinoline in mice. Fundamental & Clinical Pharmacology 31:5, pages 513-525.
Crossref
Crossref
Binbin Gong, Ming Ma, Wenjie Xie, Xiaorong Yang, Yongming Huang, Ting Sun, Yanping Luo & Jiao Huang. (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. International Urology and Nephrology 49:10, pages 1731-1740.
Crossref
Crossref
Sabrina Noel, Nadtha Panin, Mathilde Beka, Barbara Dhooghe, François Huaux & Teresinha Leal. (2017) Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms. Clinical Science 131:11, pages 1107-1121.
Crossref
Crossref
Richard Berges, Dieter Schremmer & Roger Limberg. (2017) Avanafil zur Therapie der erektilen Dysfunktion in der PraxisAvanafil for the treatment of erectile dysfunction in practice. Non-interventional study AVANTI. MMW - Fortschritte der Medizin 159:S5, pages 16-21.
Crossref
Crossref
Simona Pichini, Emilia Marchei, Roberta Pacifici, Enrico Marinelli & Francesco Paolo Busardò. (2017) Chemsex intoxication involving sildenafil as an adulterant of GHB. Drug Testing and Analysis 9:6, pages 956-959.
Crossref
Crossref
Tom MunyerJennifer Elliott. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
D. Francomano, A. Ilacqua, A. Cortese, G. Tartaglia, A. Lenzi, M. Inghilleri & A. Aversa. (2016) Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study. Journal of Endocrinological Investigation 40:3, pages 275-279.
Crossref
Crossref
Kwang-Youl KimMoonsuk NamHyun-Jung KwonKwang-Hyeon KimSeung-Hyun KangSang-Il KimCheol-Woo KimSang-Heon Cho. (2017) Validated UPLC-MS/MS method for the determination of tadalafil in human plasma and its application to a pharmacokinetic study. Translational and Clinical Pharmacology 25:1, pages 21.
Crossref
Crossref
Muhammad Atif, Muhammad Rehan Sarwar & Shane Scahill. (2016) The relationship between epilepsy and sexual dysfunction: a review of the literature. SpringerPlus 5:1.
Crossref
Crossref
Giovanni Corona, Mario Maggi & Emmanuele A. Jannini. (2016) Avanafil: The Second-Generation Treatment of Erectile Dysfunction. European Medical Journal, pages 61-69.
Crossref
Crossref
Veronika K. Jaeger & Ulrich A. Walker. (2016) Erectile Dysfunction in Systemic Sclerosis. Current Rheumatology Reports 18:8.
Crossref
Crossref
Rachel S. Rubin & Irwin Goldstein. (2016) Medical Management of Sexual Dysfunction in the Aging Male. Topics in Geriatric Rehabilitation 32:3, pages 167-173.
Crossref
Crossref
Taymour Mostafa. (2016) Useful Implications of Low-dose Long-term Use of PDE-5 Inhibitors. Sexual Medicine Reviews 4:3, pages 270-284.
Crossref
Crossref
Min Chul Cho & Jae-Seung Paick. (2016) A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction. Therapeutic Advances in Urology 8:2, pages 100-117.
Crossref
Crossref
Konstantinos Hatzimouratidis, Andrea Salonia, Ganesan Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Andrew McCullough, Luiz Otavio Torres & Mohit Khera. (2016) Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 13:4, pages 465-488.
Crossref
Crossref
A. Aversa, S. Fittipaldi, V. M. Bimonte, F. Wannenes, V. Papa, D. Francomano, E. A. Greco, A. Lenzi & S. Migliaccio. (2015) Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model. Journal of Endocrinological Investigation 39:2, pages 199-205.
Crossref
Crossref
C. Corinaldesi, L. Di Luigi, A. Lenzi & C. Crescioli. (2015) Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. Journal of Endocrinological Investigation 39:2, pages 143-151.
Crossref
Crossref
R. Pofi, D. Gianfrilli, R. Badagliacca, C. Di Dato, M. A. Venneri & E. Giannetta. (2015) Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?. Journal of Endocrinological Investigation 39:2, pages 131-142.
Crossref
Crossref
Genichiro Tsuji & Herman O. Sintim. (2016) Cyclic dinucleotide detection with riboswitch–G-quadruplex hybrid. Molecular BioSystems 12:3, pages 773-777.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
783
800
.
Zhi-wei Gao, Yun-ting Zhu, Ming-ming Yu, Bin Zan, Jia Liu, Yi-fan Zhang, Xiao-yan Chen, Xue-ning Li & Da-fang Zhong. (2015) Preclinical pharmacokinetics of TPN729MA, a novel PDE5 inhibitor, and prediction of its human pharmacokinetics using a PBPK model. Acta Pharmacologica Sinica 36:12, pages 1528-1536.
Crossref
Crossref
C. Bruni, J. Raja, C.P. Denton & M. Matucci-Cerinic. (2015) The clinical relevance of sexual dysfunction in systemic sclerosis. Autoimmunity Reviews 14:12, pages 1111-1115.
Crossref
Crossref
A Burri & H Porst. (2015) Results from an online survey investigating ED patients' insights and treatment expectations. International Journal of Impotence Research 27:5, pages 191-196.
Crossref
Crossref
Giovanni Ribaudo, Mario Angelo Pagano, Valeria Pavan, Marco Redaelli, Maira Zorzan, Raffaele Pezzani, Carla Mucignat-Caretta, Tiziano Vendrame, Sergio Bova & Giuseppe Zagotto. (2015) Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors. Fitoterapia 105, pages 132-138.
Crossref
Crossref
Giuseppe Defeudis, Daniele Gianfrilli, Chiara Di Emidio, Riccardo Pofi, Dario Tuccinardi, Andrea Palermo, Andrea Lenzi & Paolo Pozzilli. (2015) Erectile dysfunction and its management in patients with diabetes mellitus. Reviews in Endocrine and Metabolic Disorders 16:3, pages 213-231.
Crossref
Crossref
Valeria Pavan, Carla Mucignat-Caretta, Marco Redaelli, Giovanni Ribaudo & Giuseppe Zagotto. (2015) The Old Made New: Natural Compounds against Erectile Dysfunction. Archiv der Pharmazie 348:9, pages 607-614.
Crossref
Crossref
J. Chen, Z. Hu, L. Zhuan, H. Xiao, Y. Zhang & J. Yang. (2015) Intracellular calcium concentration of corpus cavernosum smooth muscle cells is decreased by the overexpression of PnNOS gene in adipose tissue-derived stem cells. Andrologia 47:6, pages 711-719.
Crossref
Crossref
Wayne J.G. Hellstrom, Jed Kaminetsky, Laurence H. Belkoff, Irwin Goldstein, James P. Tursi, Jonathan Uy, Craig A. Peterson, Charles H. Bowden & Wesley W. Day. (2015) Efficacy of Avanafil 15 Minutes after Dosing in Men with Erectile Dysfunction: A Randomized, Double-Blind, Placebo Controlled Study. Journal of Urology 194:2, pages 485-492.
Crossref
Crossref
Laurence Booth, Jane L. Roberts, Nichola Cruickshanks, Seyedmehrad Tavallai, Timothy Webb, Peter Samuel, Adam Conley, Brittany Binion, Harold F. Young, Andrew Poklepovic, Sarah Spiegel & Paul Dent. (2015) PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types. Journal of Cellular Physiology 230:5, pages 1115-1127.
Crossref
Crossref
Roland Seifert, Erich H. Schneider & Heike Bähre. (2015) From canonical to non-canonical cyclic nucleotides as second messengers: Pharmacological implications. Pharmacology & Therapeutics 148, pages 154-184.
Crossref
Crossref
Ajay K. Singh, Anas Raed & Jameela Kari. 2015. Chronic Renal Disease. Chronic Renal Disease
310
319
.
Juan Ignacio Martínez-Salamanca, Javier González, Patricia Ramírez & Javier Angulo. 2015. PanVascular Medicine. PanVascular Medicine
3887
3915
.
Toshiaki Sakamoto, Yuichi Koga, Masataka Hikota, Kenji Matsuki, Michino Murakami, Kohei Kikkawa, Kotomi Fujishige, Jun Kotera, Kenji Omori, Hiroshi Morimoto & Koichiro Yamada. (2014) The discovery of avanafil for the treatment of erectile dysfunction: A novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor. Bioorganic & Medicinal Chemistry Letters 24:23, pages 5460-5465.
Crossref
Crossref
Ghazwan Butrous. (2014) The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases. Global Cardiology Science and Practice 2014:3, pages 42.
Crossref
Crossref
Nina Schlueter, Anita de Sterke, Diana M. Willmes, Joachim Spranger, Jens Jordan & Andreas L. Birkenfeld. (2014) Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome. Pharmacology & Therapeutics 144:1, pages 12-27.
Crossref
Crossref
Ibrahim A. Abdel-Hamid, Mohamed A. Abo-Aly & Moustafa A. Elsaied. (2014) Nonresponse to PDE5 inhibitors in erectile dysfunction. Part 2. Human Andrology 4:3, pages 45-53.
Crossref
Crossref
Ibrahim A. Abdel-Hamid, Mohamed A. Abo-Aly & Moustafa A. Elsaied. (2014) Nonresponse to phosphodiesterase 5 inhibitors in erectile dysfunction. Part 1. Human Andrology 4:2, pages 23-29.
Crossref
Crossref
Michael D. Berry & Philip D. Berry. (2014) Integrative Approaches to the Treatment of Erectile Dysfunction. Current Sexual Health Reports 6:2, pages 114-123.
Crossref
Crossref
Pietro Gareri, Alberto Castagna, Davide Francomano, Gregorio Cerminara & Pasquale De Fazio. (2014) Erectile Dysfunction in the Elderly: An Old Widespread Issue with Novel Treatment Perspectives. International Journal of Endocrinology 2014, pages 1-15.
Crossref
Crossref
Juan Ignacio Martínez-Salamanca, Javier González, Patricia Ramírez & Javier Angulo. 2013. PanVascular Medicine. PanVascular Medicine
1
39
.